FHI Partners

FHI Partners was a nonprofit subsidiary of FHI 360 that worked with corporations and foundations to expand their social impact in the United States and globally. Rather than operating as a drug-development biotech, it functioned as an advisory and implementation organization that leveraged FHI 360’s health and human development capabilities. Its work appears to have included partnerships spanning global health, primary care, and noncommunicable disease access initiatives such as diabetes and hypertension programs in Nigeria. Effective October 1, 2023, FHI Partners was integrated into FHI 360 and no longer appears to operate as a distinct standalone entity.